CYP cynata therapeutics limited

2.94%

16.5¢

Clinical Trial Success Rates by Phase and Therapeutic Area |...

First 44 Last

Share
Profile

Follow
Pledge

8,663 Posts.

1455

04/02/25

11:56

Post #: 77695635
Share

Originally posted by truss20: ↑

Is he counting mining companies and supermarkets and airlines in that 1%?

If you're taking this throwaway comment as some kind of peer-reviewed proof then you're in for a rude awakening.

“It’s hard to say anything about that, other than those are the difficulties faced when you are first in class"
No, it's hard when you have no idea what you're doing and are surrounded by 'yes men' who are either too afraid or ignorant to speak up.

This is exactly why Cynata has no plans to bring their pipeline into the market themselves. Instead their strategy is to partner with bigger companies run by people who actually have experience and understand what is required and what is not for FDA approval. Case in point - why did Mesoblast submit a whole bunch of Osiris clinical data with the Rem-L paediatric results? Because they're a company run by a great salesman who's also happens to be an incompetent businessman.

Expand

Clinical Trial Success Rates by Phase and Therapeutic Area | American Council on Science and Health

SI talking fluent arse with less than 1%, it seems. I don't think the 'publicly listed' aspect would play much of a part.

Although oncology is the lowest.

Slim to no chance. I'll be amazed if they finish the P2.

Last edited by Pledge: 04/02/25

CYP Price at posting: 23.5¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

AVM

'Sure to be busy': Advance's Yuquivo drilling gets off to top start with first-hole hits

Monday's HotCopper trends: 4DS falls short, $30B bid for Santos | June 16, 2025

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

4DS

4DS Memory tanks as microchip tech tests fail to produce result

THL

Today's top gainer stock isn't an energy player. Here's what's going on

First 44 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 16.5¢		Change -0.005(2.94%)		Mkt cap ! $37.28M

Open	High	Low	Value	Volume
16.5¢	17.0¢	16.5¢	$31.42K	188.2K

Buyers (Bids)

No.	Vol.	Price($)
6	320239	16.5¢

Sellers (Offers)

Price($)	Vol.	No.
17.0¢	2200	1

View Market Depth

No.	Vol.	Price($)
6	320239	0.165
7	1307381	0.160
3	26451	0.155
3	115000	0.150
4	98937	0.140

Price($)	Vol.	No.
0.170	2200	1
0.175	21397	2
0.180	113494	5
0.185	38745	2
0.190	199688	4

Last trade - 11.55am 16/06/2025 (20 minute delay)

CYP (ASX) Chart

Clinical Trial Success Rates by Phase and Therapeutic Area |...

'Sure to be busy': Advance's Yuquivo drilling gets off to top start with first-hole hits

Monday's HotCopper trends: 4DS falls short, $30B bid for Santos | June 16, 2025

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

4DS Memory tanks as microchip tech tests fail to produce result

Today's top gainer stock isn't an energy player. Here's what's going on

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Clinical Trial Success Rates by Phase and Therapeutic Area |...

Top Stories

'Sure to be busy': Advance's Yuquivo drilling gets off to top start with first-hole hits

Monday's HotCopper trends: 4DS falls short, $30B bid for Santos | June 16, 2025

Listen: HotCopper Wire Podcast 013 - They changed the IPO rules (and that's a good thing)

4DS Memory tanks as microchip tech tests fail to produce result

Today's top gainer stock isn't an energy player. Here's what's going on

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News